Ikarian Capital’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-51,431
| Closed | -$607K | – | 138 |
|
|
2024
Q4 | $607K | Sell |
51,431
-233,284
| -82% | -$2.75M | 0.08% | 83 |
|
|
2024
Q3 | $5.87M | Sell |
284,715
-24,825
| -8% | -$512K | 0.82% | 17 |
|
|
2024
Q2 | $14M | Sell |
309,540
-249,731
| -45% | -$11.3M | 2.44% | 5 |
|
|
2024
Q1 | $21.9M | Buy |
559,271
+363,372
| +185% | +$14.3M | 2.41% | 4 |
|
|
2023
Q4 | $1.18M | Hold |
195,899
| – | – | 0.11% | 46 |
|
|
2023
Q3 | $1.32M | Buy |
195,899
+3,639
| +2% | +$24.5K | 0.16% | 42 |
|
|
2023
Q2 | $1.51M | Hold |
192,260
| – | – | 0.24% | 41 |
|
|
2023
Q1 | $1.4M | Buy |
192,260
+179,021
| +1,352% | +$1.3M | 0.32% | 42 |
|
|
2022
Q4 | $43.9K | Hold |
13,239
| – | – | 0.01% | 63 |
|
|
2022
Q3 | $66K | Sell |
13,239
-15,512
| -54% | -$77.3K | 0.01% | 62 |
|
|
2022
Q2 | $217K | Sell |
28,751
-4,503
| -14% | -$34K | 0.04% | 77 |
|
|
2022
Q1 | $530K | Buy |
33,254
+1,636
| +5% | +$26.1K | 0.07% | 97 |
|
|
2021
Q4 | $584K | Hold |
31,618
| – | – | 0.09% | 91 |
|
|
2021
Q3 | $968K | Sell |
31,618
-519
| -2% | -$15.9K | 0.07% | 94 |
|
|
2021
Q2 | $1.76M | Hold |
32,137
| – | – | 0.14% | 91 |
|
|
2021
Q1 | $1.9M | Buy |
32,137
+27,500
| +593% | +$1.62M | 0.06% | 102 |
|
|
2020
Q4 | $174K | Buy |
+4,637
| New | +$174K | 0.01% | 121 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 118 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 98 |
|